Pharma giant Eli Lilly boosts India manufacturing with $1B investment

**Pharma Giant Eli Lilly Boosts India Manufacturing with $1B Investment**

*By Mudit Dube | October 6, 2025, 2:13 PM*

Global pharmaceutical leader Eli Lilly has announced plans to invest over $1 billion in India to strengthen the country’s manufacturing and supply capabilities through local drug manufacturers. This significant move aligns with Eli Lilly’s global expansion strategy and its focus on leveraging India’s skilled workforce.

### Strategic Collaboration to Enhance Drug Availability

Eli Lilly’s investment aims to enhance the availability of several key drugs, including treatments for obesity, diabetes, Alzheimer’s disease, cancer, and autoimmune disorders. Patrik Jonsson, the company’s president of international operations, emphasized that Eli Lilly is making major investments to boost manufacturing and medicine supply capacity worldwide. He added that India is a vital hub for building capabilities within their global network.

### Current Manufacturing Approach and New Plans

At present, Eli Lilly relies on contract manufacturers in India, despite launching its blockbuster weight-loss drug Mounjaro in the country earlier this year. The pharmaceutical giant does not yet have its own manufacturing facilities in India but is collaborating with contract manufacturers to expand production capacity. Specific details of these collaborations have not been disclosed.

### Market Context and US Expansion

Eli Lilly’s investment in India comes amid increasing efforts by global drugmakers to bolster their manufacturing presence in the United States, following the Trump administration’s imposition of a 100% tariff on imported branded and patented drugs starting October 1.

Recently, Eli Lilly revealed a $5 billion investment in a new manufacturing facility in Virginia, part of its broader $27 billion expansion plan to build four new US plants over the next five years.

### New Manufacturing and Quality Facility in Hyderabad

As part of its India expansion, Eli Lilly is setting up a manufacturing and quality control facility in Hyderabad. This new hub will oversee the company’s contract manufacturing network across India and offer advanced technical capabilities. Recruitment has already begun, with plans to hire engineers, chemists, analytical scientists, and quality control and assurance experts.

—

Eli Lilly’s continued investment underscores the importance of India in its global manufacturing strategy and highlights the company’s commitment to increasing access to vital medicines worldwide.
https://www.newsbytesapp.com/news/business/eli-lilly-to-invest-1b-in-india-to-boost-manufacturing/story

You may also like

Would U.S. or Israel agree to any of Iran’s conditions to end the war?

2026 年 3 月 25 日

Son and brother of Afghan man who died in ICE custody demand answers

2026 年 3 月 18 日

‘One in a million’ malfunction rained shrapnel onto 5 Freeway near Camp Pendleton, report says

2026 年 3 月 16 日